ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,321Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 617

$748K Total Retail Price of All Prescriptions

Rank: 18 out of 617

427 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 427 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 427 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 12,003 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
FUROSEMIDE 535 473 1 4
OMEPRAZOLE 459 363 2 3
SIMVASTATIN 422 374 3 2
LEVOTHYROXINE SODIUM 361 313 4 1
WARFARIN SODIUM 358 314 5 7
AMLODIPINE BESYLATE 340 309 6 6
POTASSIUM CHLORIDE 340 295 6 10
TRAMADOL HCL 318 291 8 15
HYDROCODONE-ACETAMINOPHEN 296 202 S3 9 8
LISINOPRIL 272 251 10 5
METOPROLOL TARTRATE 245 198 11 11
GABAPENTIN 220 184 12 16
FENTANYL 219 175 S2 13 45
LOSARTAN POTASSIUM 191 189 14 22
METFORMIN HCL 186 148 15 9
BISOPROLOL-HYDROCHLOROTHIAZIDE 185 178 16 87
CHLORTHALIDONE 166 159 17 123
ALLOPURINOL 153 147 18 27
ATENOLOL 150 133 19 17
DONEPEZIL HCL 148 132 20 30
SERTRALINE HCL 148 113 20 20
METOPROLOL SUCCINATE 148 146 20 12
CITALOPRAM HBR 146 122 23 18
PRAVASTATIN SODIUM 144 144 24 21
CARVEDILOL 131 116 25 19
CARBIDOPA-LEVODOPA 126 95 26 69
POLYETHYLENE GLYCOL 3350 125 99 27 32
FENOFIBRATE 123 83 28 58
ALENDRONATE SODIUM 121 116 29 25
ENALAPRIL MALEATE 117 98 30 34
LOSARTAN-HYDROCHLOROTHIAZIDE 115 115 31 46
PAROXETINE HCL 112 108 32 62
HYDROCHLOROTHIAZIDE 108 105 33 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 107 95 34 29
NAMENDA 104 95 35 35
LANTUS 103 62 36 39
TAMSULOSIN HCL 98 74 37 26
TRAZODONE HCL 97 73 38 51
GLIMEPIRIDE 95 87 39 33
MUPIROCIN 91 65 40 176
ATORVASTATIN CALCIUM 87 84 41 14
METFORMIN HCL ER 85 85 42 72
CLOPIDOGREL 82 80 43 53
TRIAMTERENE-HCTZ 80 80 44 47
DIOVAN 78 78 45 41
CRESTOR 77 77 46 28
TRIAMTERENE-HYDROCHLOROTHIAZID 75 75 47 122
QUETIAPINE FUMARATE 74 50 48 78
MIRTAZAPINE 74 63 48 50
ISOSORBIDE MONONITRATE ER 71 69 50 52
ESCITALOPRAM OXALATE 71 46 50 65
DIOVAN HCT 66 66 52 97
WELCHOL 66 56 52 170
ADVAIR DISKUS 65 44 54 38
METHYLPREDNISOLONE 62 52 55 208
PLAVIX 56 55 56 86
BENAZEPRIL HCL 56 56 56 44
ETODOLAC 55 45 58 195
FINASTERIDE 55 51 58 104
DOXYCYCLINE HYCLATE 54 43 60 113
RAMIPRIL 53 53 61 67
JANUMET 53 44 61 310
JANUVIA 52 52 63 107
CIPROFLOXACIN HCL 51 50 64 60
LATANOPROST 51 51 64 321
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 21, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.